UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

British journal of dermatology (1951), 2016-08, Vol.175 (2), p.273-286

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

The New England journal of medicine, 2015-10, Vol.373 (14), p.1318-1328

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study

British journal of dermatology (1951), 2019-07, Vol.181 (1), p.88-95

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

British journal of dermatology (1951), 2012-09, Vol.167 (3), p.649-657

2012

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

Journal of the European Academy of Dermatology and Venereology, 2013-01, Vol.27 (1), p.125-128

2013

Link zum Volltext

Verfügbarkeit prüfen

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

The New England journal of medicine, 2021-10, Vol.385 (15), p.1382-1392

2021

Link zum Volltext

Verfügbarkeit prüfen

Measurement Properties of the patient-reported Psoriasis Symptom inventory daily diary in patients with moderate to severe Plaque Psoriasis

Value in health, 2015-05, Vol.18 (3), p.A183-A183

2015

Link zum Volltext

Verfügbarkeit prüfen

alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK

The Journal of biological chemistry, 2001-03, Vol.276 (12), p.9503-9511

2001

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and characteristics of post-acute sequelae of SARS-CoV-2 (PASC) in non-hospitalized persons with COVID-19 enrolled in a clinical trial of early treatment (ACTIV-2)

Antiviral therapy, 2021-12, Vol.26, p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

C38 BIOMARKERS OF ACUTE AND CHRONIC INFLAMMATION: Biomarker Profiles In Asthma With High Airway Reversibility And Poor Disease Control

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain

The American journal of pathology, 2001-09, Vol.159 (3), p.983

2001

Link zum Volltext

Verfügbarkeit prüfen

PSS28 - Measurement Properties of the patient-reported Psoriasis Symptom inventory daily diary in patients with moderate to severe Plaque Psoriasis

Value in health, 2015-05, Vol.18 (3), p.A183-A183

2015

Link zum Volltext

Verfügbarkeit prüfen

PSS77 - Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study

Value in health, 2015-11, Vol.18 (7), p.A429-A429

2015

Link zum Volltext

Verfügbarkeit prüfen

Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11)

Drug metabolism and disposition, 1995-12, Vol.23 (12), p.1434

1995

Link zum Volltext

Verfügbarkeit prüfen

Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study

Value in health, 2015-11, Vol.18 (7), p.A429-A429

2015

Link zum Volltext

Verfügbarkeit prüfen

Maintien d’une réponse clinique à long terme avec le brodalumab (AMG 827) dans le traitement du psoriasis : résultats à 96semaines d’une étude d’extension en ouvert

Annales de dermatologie et de vénéréologie, 2014-12, Vol.141 (12), p.S478-S479

2014

Link zum Volltext

Verfügbarkeit prüfen

Maintien d’une réponse clinique à long terme avec le brodalumab (AMG 827) dans le traitement du psoriasis : résultats à 96 semaines d’une étude d’extension en ouvert

Annales de dermatologie et de vénéréologie, 2014-12, Vol.141 (12), p.S478-S479

2014

Link zum Volltext

Verfügbarkeit prüfen

Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroids

The Journal of pharmacology and experimental therapeutics, 1995-09, Vol.274 (3), p.1450

1995

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of energy transfer on bilayer surfaces via polymerization-induced domain formation

Journal of the American Chemical Society, 1993-08, Vol.115 (17), p.7920-7921

1993

Link zum Volltext

Verfügbarkeit prüfen

Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites

Biochemistry (Easton), 1994-04, Vol.33 (14), p.4419-4424

1994

Link zum Volltext

Verfügbarkeit prüfen

Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways

The Journal of biological chemistry, 2001-08, Vol.276 (34), p.32353-32361

2001

Link zum Volltext

Verfügbarkeit prüfen

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Journal of the American Academy of Dermatology, 2020-09, Vol.83 (3), p.839-846

2020

Link zum Volltext

Verfügbarkeit prüfen

Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control

Chest, 2015-12, Vol.148 (6), p.1489-1496

2015

Link zum Volltext

Verfügbarkeit prüfen

“Soft Protein Corona” as the Stabilizer of the Methionine-Coated Silver Nanoparticles in the Physiological Environment: Insights into the Mechanism of the Interaction

International journal of molecular sciences, 2022-08, Vol.23 (16), p.8985

2022

Link zum Volltext

Verfügbarkeit prüfen

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

The New England journal of medicine, 2021-03, Vol.384 (10), p.905-914

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Humans
(10)
Female
(8)
Male
(7)
Middle Aged
(7)
Adult
(6)
Double-Blind Method
(6)
Monoclonal Antibodies
(6)
Animals
(5)
Covid-19
(5)
Dermatology
(5)
Treatment Outcome
(5)
General & Internal Medicine
(4)
Placebos
(4)
Psoriasis - Drug Therapy
(4)
Severe Acute Respiratory Syndrome Coronavirus 2
(4)
Severity Of Illness Index
(4)
Aged
(3)
Antibodies, Monoclonal, Humanized - Adverse Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

Measurement Properties of the patient-reported Psoriasis Symptom inventory daily diary in patients with moderate to severe Plaque Psoriasis

alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK

Prevalence and characteristics of post-acute sequelae of SARS-CoV-2 (PASC) in non-hospitalized persons with COVID-19 enrolled in a clinical trial of early treatment (ACTIV-2)

C38 BIOMARKERS OF ACUTE AND CHRONIC INFLAMMATION: Biomarker Profiles In Asthma With High Airway Reversibility And Poor Disease Control

Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain

PSS28 - Measurement Properties of the patient-reported Psoriasis Symptom inventory daily diary in patients with moderate to severe Plaque Psoriasis

PSS77 - Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study

Benzyloxyresorufin as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502B11)

Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study

Maintien d’une réponse clinique à long terme avec le brodalumab (AMG 827) dans le traitement du psoriasis : résultats à 96semaines d’une étude d’extension en ouvert

Maintien d’une réponse clinique à long terme avec le brodalumab (AMG 827) dans le traitement du psoriasis : résultats à 96 semaines d’une étude d’extension en ouvert

Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroids

Enhancement of energy transfer on bilayer surfaces via polymerization-induced domain formation

Structural determinants of cytochrome P450 2B1 specificity: evidence for five substrate recognition sites

Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control

“Soft Protein Corona” as the Stabilizer of the Methionine-Coated Silver Nanoparticles in the Physiological Environment: Insights into the Mechanism of the Interaction

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

Aktive Filter

Suchergebnisse filtern